New Fund
Toronto, Canada-based Cross-Border Impact Ventures held a first close of US$58M to back early- and growth-stage health technologies improving women’s and children’s health, including medical devices, diagnostics, therapeutics, and AI/ML-enabled digital health.
New York City-based OrbiMed secured $3 billion to back life sciences and...
Toronto, Canada-based Genesys Capital announced the second close of its...
Brooklyn, NY-based SEVA Growth closed a $160m second growth equity fund to...
<p>USA-based <a href="http://facktorhealth.com">Facktor Ventures</a>...
Boston-based Stride Consumer Partners closed a $550m fund to back...
New York City-based Solari Capital launched (size undisclosed) to invest...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
